What does Epicore Biosystems do?
Epicore Biosystems develops clinically validated sweat-sensing wearables and cloud analytics that deliver real-time, personalized health insights, with products licensed by Fortune 1000 companies, the Department of Defense, and the National Institute of Health.
How much did they raise?
The company raised an extra $6M in a Series B round, with lead investors including Alumni Ventures and Joyance Partners, adding to its previous $26M raise to bring the total Series B funding to $32M.
What are their plans for the money?
The new funds will be used to expand operations and accelerate the development and commercialization of its innovative digital health solutions, potentially enhancing patient monitoring and personalized care globally.
What have they achieved so far?
Epicore Biosystems has already made significant progress with its clinically validated biowearables and established global licensing agreements with major corporations and government agencies.
